NiceRx review

NiceRx publishes prices for NAD⁺ injection, nasal spray and face cream, plus glutathione and sermorelin. The useful comparison is the full paid term: its “monthly” plans cover four weeks, and lower advertised averages require longer prepayment. Its website names six pharmacy options and the Nice Health medical groups. Check the renewal-processing date before committing; the terms allow early billing and require two days’ cancellation notice.

NiceRx LLC provides a platform for prescription weight-loss, longevity and strength treatment through independent clinicians. Its current catalog includes compounded semaglutide and tirzepatide injections and microdose programs, NAD⁺ injection, nasal spray and face cream, glutathione, B12, MIC+B12, and sermorelin injection and tablets. This is a paid treatment service rather than a manufacturer patient-assistance program.

Nice Health, P.A. and Nice Health, P.C. provide the clinical services. The terms name MFV Pharmacy, Formulation Compounding Center, OptioRx, PerfectRx Pharmacy, Absolute Pharmacy and Rush Pharmacy as fulfillment options; the pharmacy for an individual prescription still needs confirmation. NiceRx states that evaluation, medication and delivery are included, with no separate membership or shipping fee and no dose-based price increase. The FAQ excludes Alaska, Mississippi, New Jersey and Kansas, and notes that individual medicines may have further restrictions. The service is for adults; a clinician must decide whether treatment is appropriate.

NAD⁺ injection is $189 per four-week cycle. The longer prepaid charges are $519 for 12 weeks, $936 for 24 weeks and $1,788 for 48 weeks. Nasal spray is $119 per four weeks, or $299/$559/$1,039 for those longer terms. Face cream is $79 per four weeks, or $229/$449/$869. Those are different routes, not interchangeable treatments.

Sermorelin injection is $155 per four weeks, $417 per 12 weeks or $768 per 24 weeks; tablets are $149, $429 or $822 for the same terms. Glutathione injection is $129 per four weeks, or $270/$492/$864 for 12/24/48 weeks. B12 and MIC+B12 are also listed. The product tables publish the full charges alongside lower “per month” averages; a 48-week plan is not a full calendar year.

For weight loss, standard semaglutide is $149 per four weeks or $299/$569/$1,075 for 12/24/48 weeks. Tirzepatide is $249 or $449/$885/$1,749. Microdose programs have separate prices. A $50 first-month discount is advertised for GLP-1 plans and most longevity and strength products, including longer plans; confirm its application rather than treating a discounted figure as the standing charge.

Plans are prepaid for the selected term and renew on the same schedule. Cancel by email, phone or account message at least two days before renewal processing. The first renewal may be early, and the terms allow charges and shipping up to ten days early for operational reasons. Partially used periods are generally nonrefundable, with discretionary exceptions. Ask for the actual processing date before relying on the nominal renewal date.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. NiceRx sells compounded preparations only — no brand-name products — and while it states that every batch is tested for sterility and potency, compounded preparations are not reviewed by the FDA for purity and potency the way approved drugs are, and the pharmacy for a particular prescription must be confirmed. On evidence, the anti-aging shelf is where the claims outrun the data. Injected and intranasal NAD⁺ have no controlled human outcome trials; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The topical face cream has less support again — there is no controlled human outcome evidence for topical NAD⁺ at all. The NAD⁺ forms with human data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, which reliably raise blood NAD⁺ levels; that is a raised biomarker, not a demonstrated clinical benefit, and it is worth understanding that the routes NiceRx sells are not the routes that were studied. Glutathione has essentially no controlled human outcome data. Sermorelin is the strongest name on the menu: a GHRH analog acting on a real, well-described pituitary axis, with thin long-term human outcome data. Individual results vary.